Presence of circulating levels of interferon-γ, interleukin-10 and tumor necrosis factor-α in patients with visceral leishmaniasis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 40, Issue 1, 1998, Pages 31-34

  De Medeiros, Iara Marques ^a,b   Castelo, Adauto ^a   Salomão, Reinaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Cytokines; IFN ; IL 10; TNF ; Visceral Leishmaniasis (Kala Azar)

Indexed keywords

AMPHOTERICIN B; ANTIMONY; ANTIPROTOZOAL AGENT; GAMMA INTERFERON; INTERLEUKIN 10; MEGLUMINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; PRESCHOOL CHILD; TIME; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIMONY; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031608525     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-46651998000100007     Document Type: Article

References (19)

1. BARRAL-NETO, M.; BADARÓ, R.; BARRAL, A. et al. - Tumor necrosis factor (Cachectin) in human visceral leishmaniasis. J. infect. Dis., 163: 853-857, 1991.
2. CARVALHO, E. M.; BADARÓ, R.; REED, S. G. et al. - Absence of gamma-interferon and interleukin-production during active visceral leishmaniasis. J. clin. Invest., 76: 2066-2069, 1985.
3. CARVALHO, E. M.; BACELLAR, O., BROWNELL, C. et al. - Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol., 152: 5949-5956, 1994.
4. DEL PRETE, G.; DE CARLI, M.; ALMERIGOGNA, F. et al. - Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 150: 353-360, 1993.
5. GHALIB, H. W.; PIUVEZAM, M. R.; SKEIKY, Y. A. W. et al. - Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. clin. Invest., 92: 324-329, 1993.
6. HEINZEL, F. P.; SADICK, M. D.; HOLADAY, B. J. et al. - Reciprocal expression of interferon-gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. exp. Med., 169: 59-72, 1989.
7. HO, J. L.; BADARÓ, R.; SCHWARTZ, A. et al. - Diminished in vitro production of interleukin-1 and tumor necrosis factor-α during acute visceral Leishmaniasis and recovery after therapy. J. infect. Dis., 165: 1094-1102, 1992.
8. HOLADAY, B. J.; POMPEU, M. M. L.; JERONIMO, S. et al. - Potencial role for interleukin-10 in the immunosupression associated with Kala-azar. J. clin. Invest., 92: 2626-2632, 1993.
9. KARP, C. L.; EL-SAFI, S. H.; WYNN, T. A. et al. - In vitro cytokine profiles in patients with kala-azar: marked elevation of both interleukin-10 and interferon-gamma. J. clin. Invest., 91: 1644-1648, 1993.
10. LILES, W. C. & VAN VOORHIS, W. C. - Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. infect. Dis., 172: 1573-1580, 1995.
11. MOSMANN, T. R. - Properties and functions of interleukin-10. Advanc. Immunol., 56: 1-26, 1994.
12. MURRAY, H. W.; STERN, J. J.; WELTE, K. et al. - Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction and response to treatment with interleukin 2 and interferon-gamma. J. Immunol., 138: 2290-2297, 1987.
13. PEARSON, R. D. & SOUZA, A. Q. - Leishmania species: visceral (kala-azar), cutaneous and mucosal leishmaniasis. In: MANDELL, G. L.; DOUGLAS, R. G. & BENNETT, J. B. Principles and pratice of infectious diseases. 3. ed. New York, Churchill Livingstone, 1990. p. 2066-2077.
14. PISA, P.; GENNENE, M.; SÖDER, O. et al. - Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J. infect. Dis., 161: 988-991, 1990.
15. POWRIE, F.; MENON, S.; COFFMAN, R. L. - Interleukin 4 and interleukin 10 synergize to inhibit cell-mediated immunity in vivo. Europ. J. Immunol., 23: 3043-3049, 1993.
16. SALOMÃO, R.; CASTELO FILHO, A.; MEDEIROS, I. M. et al. - Plasma levels of tumor necrosis factor-α in patients with visceral leishmaniasis (kala-azar). Association with activity of the disease and clinical remission following antimonial therapy. Rev. Inst. Med. trop. S. Paulo, 38: 113-118, 1996.
17. SKEIKY, Y. A. W.; GUDERIAN, J. A.; BENSON, D. R. et al. - A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells express a Th1-type cytokine profile and to produce interleukin 12. J. exp. Med., 181: 1527-1537, 1995.
18. TITUS, R. G.; SHERRY, B. & CERAMI, A. - Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. exp. Med., 170: 2097-2104, 1989.
19. TUMANG, M. C. T.; KEOGH, C.; MOLDAWER, L. L. et al. - Role and effect of TNF-α in experimental visceral leishmaniasis. J. Immunol., 153: 768-775, 1994.